吸烟与结直肠癌风险:总体及按分子亚型的荟萃分析
该研究系统检索并荟萃分析了截至2018年9月发表的188项原始研究,评估吸烟与结直肠癌风险的关系。结果显示,当前吸烟者与既往吸烟者的结直肠癌风险均升高,且风险随吸烟强度和年限呈线性增加,戒烟可使风险降低。吸烟与微卫星高度不稳定、CpG岛甲基化表型阳性及BRAF突变型结直肠癌风险升高密切相关,而与KRAS、TP53突变型无关。
要点
- 与从不吸烟者相比,当前吸烟者和既往吸烟者的结直肠癌风险均升高。
- 戒烟超过25年者结直肠癌风险较当前吸烟者显著降低。
- 吸烟与微卫星高度不稳定、CpG岛甲基化表型阳性及BRAF突变型结直肠癌风险升高相关。
核心结论
- 吸烟以剂量依赖方式增加结直肠癌风险,戒烟可降低该风险。
- 吸烟大幅增加经微卫星不稳定通路发生的结直肠癌风险,该通路特征为微卫星高度不稳定、CpG岛甲基化表型阳性及BRAF突变。
研究设计与样本
- 系统综述与荟萃分析,纳入截至2018年9月发表的188项原始研究。
- 按吸烟状态、强度、年限、包年及戒烟时间计算结直肠癌的相对风险(RR),并关注分子亚型。
主要发现
- 与从不吸烟者相比,当前吸烟者的结直肠癌合并RR为1.14(95%CI 1.10-1.18)。
- 与从不吸烟者相比,既往吸烟者的结直肠癌合并RR为1.17(95%CI 1.15-1.20)。
- 结直肠癌风险随吸烟强度和年限线性增加。
- 戒烟超过25年的既往吸烟者结直肠癌风险较当前吸烟者显著降低。
- 吸烟与CpG岛甲基化表型阳性(RR 1.42;95%CI 1.20-1.67;研究数n=4)、BRAF突变(RR 1.63;95%CI 1.23-2.16;n=4)及微卫星高度不稳定(RR 1.56;95%CI 1.32-1.85;n=8)的结直肠癌风险强烈相关,而与KRAS突变(RR 1.04;95%CI 0.90-1.20;n=5)及TP53突变(RR 1.13;95%CI 0.99-1.29;n=5)无关。
关键数值与推荐
- 当前吸烟者结直肠癌合并RR为1.14(95%CI 1.10-1.18),对照为从不吸烟者。
- 既往吸烟者结直肠癌合并RR为1.17(95%CI 1.15-1.20),对照为从不吸烟者。
- CpG岛甲基化表型阳性结直肠癌RR为1.42(95%CI 1.20-1.67;n=4)。
- BRAF突变结直肠癌RR为1.63(95%CI 1.23-2.16;n=4)。
- 微卫星高度不稳定结直肠癌RR为1.56(95%CI 1.32-1.85;n=8)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The aim of this study was to provide the most comprehensive and up-to-date evidence on the association between cigarette smoking and colorectal cancer (CRC) risk. METHODS: We conducted a systematic review and meta-analysis of epidemiological studies on the association between cigarette smoking and CRC risk published up to September 2018. We calculated relative risk (RR) of CRC according to smoking status, intensity, duration, pack-years, and time since quitting, with a focus on molecular subtypes of CRC. RESULTS: The meta-analysis summarizes the evidence from 188 original studies. Compared with never smokers, the pooled RR for CRC was 1.14 (95% confidence interval [CI] 1.10-1.18) for current smokers and 1.17 (95% CI 1.15-1.20) for former smokers. CRC risk increased linearly with smoking intensity and duration. Former smokers who had quit smoking for more than 25 years had significantly decreased risk of CRC compared with current smokers. Smoking was strongly associated with the risk of CRC, characterized by high CpG island methylator phenotype (RR 1.42; 95% CI 1.20-1.67; number of studies [n] = 4), BRAF mutation (RR 1.63; 95% CI 1.23-2.16; n = 4), or high microsatellite instability (RR 1.56; 95% CI 1.32-1.85; n = 8), but not characterized by KRAS (RR 1.04; 95% CI 0.90-1.20; n = 5) or TP53 (RR 1.13; 95% CI 0.99-1.29; n = 5) mutations. DISCUSSION: Cigarette smoking increases the risk of CRC in a dose-dependent manner with intensity and duration, and quitting smoking reduces CRC risk. Smoking greatly increases the risk of CRC that develops through the microsatellite instability pathway, characterized by microsatellite instability-high, CpG island methylator phenotype positive, and BRAF mutation.
引用
- Botteri E, Borroni E, Sloan EK, et al. Smoking and Colorectal Cancer Risk, Overall and by Molecular Subtypes: A Meta-Analysis. Am J Gastroenterol. 2020. PMID: 32773458. doi:10.14309/ajg.0000000000000803
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。